Evidence, Education and Practice
Open Access
- 1 October 2006
- journal article
- review article
- Published by S. Karger AG in Cerebrovascular Diseases
- Vol. 22 (5-6) , 342-349
- https://doi.org/10.1159/000094849
Abstract
Stroke causes greater loss of quality-adjusted life years than any other disease and is also one of the most expensive disorders. The burden of stroke will increase in the future due to change in the age structure of populations. We have a vast body of evidence on how to prevent stroke and how to treat stroke patients. Good examples are treatment of hypertension, antithrombotic agents and carotid surgery in stroke prevention, thrombolysis in ischaemic stroke and stroke unit care for all stroke patients. We only have to translate scientific evidence into daily practice. If some pieces are missing, it is our duty to generate them through research. While taking part in randomized clinical trials (RCTs), the discipline, an essential part of RCTs, will improve the daily care of all stroke patients. Besides RCTs there are many other sources of scientific evidence for stroke management, one of which is the European Stroke Initiative (EUSI). The mission of the EUSI is to improve and optimize stroke management in Europe through education and by offering best practice guidelines. Also national and international societies and organizations play an important role in providing education. The human factor is one obstacle to more successful stroke management because to be more effective we must change our own clinical routine. We can make a difference by applying available evidence to our daily practice.Keywords
This publication has 98 references indexed in Scilit:
- Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS)Stroke, 2006
- Continuous 15-Year Decrease in Incidence and Mortality of Stroke in FinlandStroke, 2004
- Community-Based Thrombolytic Therapy of Acute Ischemic Stroke in HelsinkiStroke, 2003
- AMPA Antagonist ZK200775 in Patients With Acute Ischemic StrokeStroke, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Cyclooxygenase‐2 is induced globally in infarcted human brainAnnals of Neurology, 1998
- MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosisThe Lancet, 1991
- Platelet thromboxane release after subarachnoid hemorrhage and surgeryStroke, 1990
- Stroke and mortality rate in carotid endarterectomy: 228 consecutive operations.Stroke, 1977